TMO logo

Thermo Fisher Scientific Inc. Stock Price

NYSE:TMO Community·US$193.7b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 215 Fair Values set on narratives written by author

TMO Share Price Performance

US$513.68
-19.61 (-3.68%)
US$641.57
Fair Value
US$513.68
-19.61 (-3.68%)
19.9% undervalued intrinsic discount
US$641.57
Fair Value
Price US$513.68
AnalystConsensusTarget US$641.57
AnalystHighTarget US$742.76
Unike US$540.27

TMO Community Narratives

AnalystConsensusTarget·
Fair Value US$641.57 19.9% undervalued intrinsic discount

Life Science Leadership And Pharma Partnerships Will Drive Long-Term Market Momentum

0users have liked this narrative
0users have commented on this narrative
78users have followed this narrative
AnalystHighTarget·
Fair Value US$742.76 30.8% undervalued intrinsic discount

Aging Populations And Gene Therapies Will Drive Precision Medicine

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Unike·
Fair Value US$540.27 4.9% undervalued intrinsic discount

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

1users have liked this narrative
0users have commented on this narrative
23users have followed this narrative
US$575
10.7% undervalued intrinsic discount
Revenue
5.29% p.a.
Profit Margin
18.98%
Future PE
27.81x
Price in 2029
US$726.11

Trending Discussion

Updated Narratives

TMO logo

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

Fair Value: US$540.27 4.9% undervalued intrinsic discount
23 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TMO logo

TMO: 2026 Tools Recovery And AI Partnerships Will Drive Earnings Power

Fair Value: US$742.76 30.8% undervalued intrinsic discount
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TMO logo

TMO: Raised 2026 Expectations And Policy Risks Will Pressure Future Returns

Fair Value: US$575 10.7% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with proven track record.

1 Risk
5 Rewards

Thermo Fisher Scientific Inc. Key Details

US$44.6b

Revenue

US$26.0b

Cost of Revenue

US$18.6b

Gross Profit

US$11.9b

Other Expenses

US$6.7b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
17.84
41.68%
15.05%
73.6%
View Full Analysis

About TMO

Founded
1956
Employees
125000
CEO
Marc Casper
WebsiteView website
www.thermofisher.com

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Recent TMO News & Updates

Recent updates

No updates